Skip to content

Advertisement

  • Correction
  • Open Access

Correction to: Open-label pilot for treatment targeting gut dysbiosis in myalgic encephalomyelitis/chronic fatigue syndrome: neuropsychological symptoms and sex comparisons

Journal of Translational Medicine201816:39

https://doi.org/10.1186/s12967-018-1413-y

  • Received: 14 February 2018
  • Accepted: 14 February 2018
  • Published:

The original article was published in Journal of Translational Medicine 2018 16:24

Correction to: J Transl Med (2018) 16:24 https://doi.org/10.1186/s12967-018-1392-z

The original version of this article [1], published on 6 February 2018, contains a mistake in the ‘Conclusions’ section. The corrected version of the affected sentence is given below and the corrected part is marked in bold.
  • It is unclear whether the reduction in Streptococcus is particularly beneficial in some ME/CFS patients or whether other concurrent microbial shifts are equally or more valuable (i.e., increased Bacteroides and/or reduced Clostridium).

Notes

Declarations

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Psychology Department, College of Health and Biomedicine, Victoria University, Melbourne, Australia
(2)
Bioscreen (Aust) Pty Ltd., Melbourne, Australia
(3)
CFS Discovery Clinic, Donvale, Melbourne, Australia
(4)
College of Engineering and Science, Victoria University, Melbourne, Australia

Reference

  1. Wallis A, Ball M, Butt H, Lewis DP, McKechnie S, Paull P, Jaa-Kwee A, Bruck D. Open-label pilot for treatment targeting gut dysbiosis in myalgic encephalomyelitis/chronic fatigue syndrome: neuropsychological symptoms and sex comparisons. J Transl Med. 2018;16:24. https://doi.org/10.1186/s12967-018-1392-z.View ArticlePubMedPubMed CentralGoogle Scholar

Copyright

Advertisement